Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sorina N. Badelita"'
Autor:
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina N. Badelita
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 174-183 (2023)
Abstract Clinical trials have demonstrated the efficacy and safety of carfilzomib in patients with relapsed/refractory multiple myeloma (RRMM); however, prospective real‐world data are limited. This real‐world, prospective, observational study ev
Externí odkaz:
https://doaj.org/article/37cd25a7f41e48c4ad559bd240ebb922
Autor:
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina N. Badelita
Publikováno v:
eJHaem. 4:174-183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9e405ab4e16edb0439b39c4d08158d
https://doi.org/10.1002/jha2.595
https://doi.org/10.1002/jha2.595
Autor:
Evangelos Terpos, Renato Zambello, Xavier Leleu, Thomas Kuehr, Sorina N. Badelita, Eirini Katodritou, Alessandra Brescianini, Tony Liang, Sally Wetten, Jo Caers
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5311
This prospective, observational study examined the real-world use of carfilzomib across 11 European countries in adults with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy. Carfilzomib and dexamethasone (K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1435f9a896f4a89458460d325fc664
https://doi.org/10.3390/cancers14215311
https://doi.org/10.3390/cancers14215311